sur Biophytis (EPA:ALBPS)
Biophytis Participates in First Longevity Summit
Biophytis SA, a pioneer in transformative longevity therapies, announced its participation in the inaugural Longevity Summit 2026. The event took place at the French National Academy of Medicine in Paris, supported by French President Emmanuel Macron. The summit is a pivotal gathering in France, dedicated to addressing challenges in healthy aging. It brought together 150 leaders from various sectors to discuss geroscience advancements, AI healthcare applications, and aging prevention strategies.
Biophytis' involvement underscores its commitment to contributing to aging management discourse. The company showcased its therapeutic approach focused on mobility and autonomy. CEO Stanislas Veillet engaged in panel discussions with experts on aging-related challenges. This aligns with Biophytis' strategy of leading in age-related disease solutions.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Biophytis